siRNA treatment reduces triglycerides in people with unusual disorder

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran lowered triglyceride degrees by 80% as well as decreased the risk of pancreatitis in clients with consistent chylomicronemia, with or without a hereditary diagnosis.